Biljana Stankovic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

MADCAM1 Gene Variants as Potential Pharmacogenomics Markers for Vedolizumab Response in Crohn's Disease Bio-Naïve Patients.

MADCAM1 Gene Variants as Potential Pharmacogenomics Markers for Vedolizumab Response in Crohn's Disease Bio-Naïve Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: June 01, 2026

Correction: Tosic et al. High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci. 2025, 26, 1153.

Correction: Tosic et al. High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. Int. J. Mol. Sci. 2025, 26, 1153.

Journal: International journal of molecular sciences

Published: December 03, 2025

Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis.

Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn's Disease Patients: A Rare-Variant Analysis.

Journal: Biomedicines

Published: August 26, 2025

Comprehensive pharmacogenomics profiling of the Serbian population.

Comprehensive pharmacogenomics profiling of the Serbian population.

Journal: Frontiers in pharmacology

Published: December 30, 2024

High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia.

High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia.

Journal: International journal of molecular sciences

Published: December 27, 2024

NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease.

NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 14, 2024

The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity.

The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity.

Journal: Frontiers in pharmacology

Published: June 12, 2024

Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation.

Psychological Distress Is Associated With Inflammatory Bowel Disease Manifestation and Mucosal Inflammation.

Journal: Inflammatory bowel diseases

Published: February 29, 2024

Introducing community-based mental health support in Serbia: A qualitative study on experiences and needs of long-term psychiatric users.

Introducing community-based mental health support in Serbia: A qualitative study on experiences and needs of long-term psychiatric users.

Journal: Global mental health (Cambridge, England)

Published: December 12, 2023

Micronutrients, genetics and COVID-19.

Micronutrients, genetics and COVID-19.

Journal: Current opinion in clinical nutrition and metabolic care

Published: May 05, 2023

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease.

Genetic Aspects of Micronutrients Important for Inflammatory Bowel Disease.

Journal: Life (Basel, Switzerland)

Published: September 05, 2022

Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population.

Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population.

Journal: Frontiers in genetics

Published: April 01, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026